Early reduction of the splicing factor2/alternative splicing factor: a cellular inhibitor of the JC polyomavirus in natalizumab-treated MS patients long before developing progressive multifocal leukoencephalopathy 8. maj 2020Bio-kemi, metaboliske processer og DNA(link-samling), Forebyggelse, Præventive Strategier & Immunitet, Hjernen & Central-Nerve-Systemet, Inflammation & Auto-Immun-Sygdomme, Sundheds-emner(link-samling), Videnskabelige ArtiklerIngen kommentarerJon Ch. Henningsen
